Published in Epidemiol Infect on December 01, 1998
Significance of fomites in the spread of respiratory and enteric viral disease. Appl Environ Microbiol (2007) 2.05
Are we aware how contaminated our mobile phones with nosocomial pathogens? Ann Clin Microbiol Antimicrob (2009) 1.55
Cell phones and Acinetobacter transmission. Emerg Infect Dis (2005) 1.23
Transfer efficiency of bacteria and viruses from porous and nonporous fomites to fingers under different relative humidity conditions. Appl Environ Microbiol (2013) 0.97
Comparison of surface sampling methods for virus recovery from fomites. Appl Environ Microbiol (2011) 0.90
Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut (2003) 2.70
Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee. J Natl Cancer Inst (1993) 2.22
Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureus. J Med Microbiol (1998) 1.76
Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production. J Clin Invest (1997) 1.68
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. J Clin Oncol (2001) 1.62
Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol (2001) 1.61
Cisplatin and its analogues in the treatment of advanced breast cancer: a review. Br J Cancer (1992) 1.56
Prognostic value of angiogenesis in operable non-small cell lung cancer. J Pathol (1996) 1.42
Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4. Nature (1994) 1.35
Leptin acts as a mitogenic and antiapoptotic factor for colonic cancer cells. Br J Surg (2007) 1.32
Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer (1995) 1.30
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br J Cancer (1995) 1.29
Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer (1997) 1.25
Comparison of prognostic factors in patients in phase I trials of cytotoxic drugs vs new noncytotoxic agents. Br J Cancer (2003) 1.25
Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion. J Biol Chem (1998) 1.20
Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer. Int J Cancer (1997) 1.19
Reasons given by patients for participating, or not, in Phase 1 cancer trials. Eur J Cancer (2011) 1.18
Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum (1986) 1.10
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions. Clin Cancer Res (1999) 1.09
Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells. Am J Physiol (1998) 1.09
Immune-related intestinal Cl- secretion. I. Effect of histamine on the T84 cell line. Am J Physiol (1988) 1.09
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Clin Cancer Res (2000) 1.08
Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src). J Biol Chem (2000) 1.07
Functional characteristics of mucosal and connective tissue mast cells of man, the rat and other animals. Int Arch Allergy Appl Immunol (1985) 1.07
A biologic function for an "orphan" messenger: D-myo-inositol 3,4,5,6-tetrakisphosphate selectively blocks epithelial calcium-activated chloride channels. Proc Natl Acad Sci U S A (1996) 1.05
Epidermal growth factor inhibits Ca(2+)-dependent Cl- transport in T84 human colonic epithelial cells. Am J Physiol (1996) 1.05
Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours. Ann Oncol (1999) 1.02
Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. Clin Cancer Res (2001) 1.02
Mast cell heterogeneity: evidence and implications. J Clin Immunol (1984) 1.01
Elevation of inositol tetrakisphosphate parallels inhibition of Ca(2+)-dependent Cl- secretion in T84 cells. Am J Physiol (1993) 1.01
Membrane-permeant derivatives of cyclic AMP optimized for high potency, prolonged activity, or rapid reversibility. Mol Pharmacol (1994) 1.00
Activation of mast cells by bile acids. Gastroenterology (1991) 1.00
Familial autoimmune haemolytic anaemia associated with rheumatoid arthritis and pernicious anaemia. Br J Haematol (1970) 1.00
Phosphatidylinositol 3-kinase mediates the inhibitory effect of epidermal growth factor on calcium-dependent chloride secretion. J Biol Chem (1996) 1.00
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer. Br J Cancer (2011) 0.99
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects. Clin Cancer Res (1999) 0.97
Mast cells and histamine contribute to bile acid-stimulated secretion in the mouse colon. J Clin Invest (1995) 0.97
Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP. J Biol Chem (1993) 0.96
Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000. J Clin Oncol (2003) 0.96
A role for protein kinase cepsilon in the inhibitory effect of epidermal growth factor on calcium-stimulated chloride secretion in human colonic epithelial cells. J Biol Chem (2000) 0.94
The effect of cryoprecipitate concentrate in patients with classical haemophilia. Lancet (1967) 0.94
Inhibition of IgE-mediated mast cell degranulation by sulphasalazine. Eur J Pharmacol (1985) 0.94
Modulation of bryostatin 1 muscle toxicity by nifedipine: effects on muscle metabolism and oxygen supply. Br J Cancer (1996) 0.92
Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule. J Clin Oncol (1993) 0.92
A phase II study of bryostatin 1 in metastatic malignant melanoma. Br J Cancer (1998) 0.91
A comparison of histamine secretion from isolated peritoneal mast cells of the mouse and rat. Int Arch Allergy Appl Immunol (1983) 0.91
Phase II study of single agent capecitabine in the treatment of metastatic non-pancreatic neuroendocrine tumours. Br J Cancer (2011) 0.90
Mast cells isolated from guinea-pig lung: characterization and studies on histamine secretion. Agents Actions (1983) 0.90
Possible mechanisms of diarrheal side effects associated with the use of a novel chemotherapeutic agent, flavopiridol. Clin Cancer Res (2001) 0.89
Activation of transglutaminase and production of protein-bound gamma-glutamylhistamine in stimulated mouse mast cells. J Biol Chem (1985) 0.89
Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Gastroenterology (1997) 0.89
Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity. Am J Physiol Cell Physiol (2001) 0.89
Mast cells are not essential to inflammation in murine model of colitis. Dig Dis Sci (1994) 0.87
Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069. Br J Cancer (1997) 0.87
Mast cell heterogeneity in higher animals: a comparison of the properties of autologous lung and intestinal mast cells from nonhuman primates. J Immunol (1986) 0.86
A comparative study of histamine secretion from rat peritoneal and pleural mast cells. Agents Actions (1982) 0.85
Dual role for AlF4(-)-sensitive G proteins in the function of T84 epithelial cells: transport and barrier effects. Am J Physiol (1997) 0.85
Effects of quercetin on epithelial chloride secretion. Life Sci (1997) 0.85
Cross-talk between calcium and cAMP-dependent intracellular signaling pathways. Implications for synergistic secretion in T84 colonic epithelial cells and rat pancreatic acinar cells. J Clin Invest (1995) 0.85
Regulation of chloride secretion. Novel pathways and messengers. Ann N Y Acad Sci (2000) 0.85
A phase 1 study of tazarotene in adults with advanced cancer. Br J Cancer (2003) 0.84
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer. Br J Cancer (1998) 0.84
Expression of acid-sensing ion channels in intestinal epithelial cells and their role in the regulation of duodenal mucosal bicarbonate secretion. Acta Physiol (Oxf) (2010) 0.83
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer. Br J Cancer (2004) 0.83
Cloning, expression, signaling mechanisms, and membrane targeting of P2Y(11) receptors in Madin Darby canine kidney cells. Mol Pharmacol (2001) 0.83
Dual effects of a phorbol ester on calcium-dependent chloride secretion by T84 epithelial cells. Am J Physiol (1992) 0.83
Phosphatidic acid modulates Cl- secretion in T84 cells: varying effects depending on mode of stimulation. Am J Physiol (1993) 0.83
Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha. Br J Cancer (2000) 0.83
Phosphatidylinositol 3-kinase-dependent pathways oppose Fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells. Implications for inflammatory diarrheal states. J Biol Chem (2001) 0.83
The development of a structured rating schedule (the BAS) to assess skills in breaking bad news. Br J Cancer (1999) 0.83
The mucosal mast cell and its role in gastrointestinal allergic diseases. Clin Rev Allergy (1984) 0.83
Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer. Br J Cancer (1999) 0.83
ErbB2 and ErbB3 receptors mediate inhibition of calcium-dependent chloride secretion in colonic epithelial cells. J Biol Chem (1999) 0.82
A rapid immunoassay method for the direct detection of PCR products: application to detection of TEM beta-lactamase genes. J Med Microbiol (1996) 0.82
Bradykinin regulates human colonic ion transport in vitro. Br J Pharmacol (2008) 0.81
Some observations on the reversibility of methotrexate toxicity in normal proliferating tissues. J Natl Cancer Inst (1977) 0.81
Histamine secretion from mast cells treated with chlortetracycline (aureomycin): a novel calcium ionophore. Agents Actions (1983) 0.81
Heterogeneity of mast cells in the tissues of the respiratory tract and other organ systems. Am Rev Respir Dis (1987) 0.81
Phase II trial of the antiangiogenic agent IM862 in metastatic renal cell carcinoma. Br J Cancer (2004) 0.81
Activation by calcium alone of chloride secretion in T84 epithelial cells. Br J Pharmacol (1993) 0.81
Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignancies. Ann Oncol (2003) 0.80
Decoding epithelial signals: critical role for the epidermal growth factor receptor in controlling intestinal transport function. Acta Physiol (Oxf) (2008) 0.80
The histologic and functional characterization of enzymatically dispersed intestinal mast cells of nonhuman primates: effects of secretagogues and anti-allergic drugs on histamine secretion. J Immunol (1985) 0.80
Evaluation of the alkaline comet assay and urinary 3-methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen. Cancer Chemother Pharmacol (2000) 0.79
Utility of endoscopic biopsy samples to quantitate human duodenal ion transport. J Lab Clin Med (1998) 0.79
A pilot study of mitomycin, cisplatin and continuous infusion 5-fluorouracil (MCF) in advanced non-small-cell lung cancer. Br J Cancer (1995) 0.79
Alterations in Fc epsilon RI induced by protoporphyrin plus long-wavelength ultraviolet light in mouse bone marrow-derived mast cells. J Immunol (1993) 0.79
A role for guanylate cyclase C in acid-stimulated duodenal mucosal bicarbonate secretion. Am J Physiol Gastrointest Liver Physiol (2003) 0.79
The effects of aspartame on mast cells and basophils. Food Chem Toxicol (1986) 0.78
Differential effects of apical and basolateral uridine triphosphate on intestinal epithelial chloride secretion. Am J Physiol Cell Physiol (2001) 0.78
Inhibition of rabbit duodenal bicarbonate secretion by ulcerogenic agents: histamine-dependent and -independent effects. Gastroenterology (1998) 0.78
Studies on histamine secretion from enzymically dispersed cutaneous mast cells of the rat. J Invest Dermatol (1985) 0.78
Histamine release from rodent and human mast cells induced by protoporphyrin and ultraviolet light: studies of the mechanism of mast-cell activation in erythropoietic protoporphyria. Br J Dermatol (1990) 0.78
A novel cyclic adenosine monophosphate analog induces hypercalcemia via production of 1,25-dihydroxyvitamin D in patients with solid tumors. J Clin Endocrinol Metab (1997) 0.78
Thymidine phosphorylase moderates thymidine-dependent rescue after exposure to the thymidylate synthase inhibitor ZD1694 (Tomudex) in vitro. Cancer Res (1998) 0.78
Role of histamine in a rat model of colitis. Inflamm Res (1995) 0.78
AMP and microamps: neutrophil-derived chloride secretagogue identified. J Clin Invest (1993) 0.78
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tract. Ann Oncol (1997) 0.77
Histamine release from the cultured mouse mast cell line PT18 in response to immunologic and non-immunologic stimuli. Agents Actions (1984) 0.77
Enhanced tissue responsiveness in colonic ion transport of cow's milk-sensitized guinea pigs. Agents Actions (1994) 0.77